Clinical and study characteristics of controls and the patients with heart failure with reduced or preserved ejection fraction.
- Shunsuke Tamaki (435263)
- Toshiaki Mano (435264)
- Yasushi Sakata (435265)
- Tomohito Ohtani (435266)
- Yasuharu Takeda (435267)
- Daisuke Kamimura (435268)
- Yosuke Omori (435269)
- Yasumasa Tsukamoto (435270)
- Yukitoshi Ikeya (435271)
- Mari Kawai (435272)
- Atsushi Kumanogoh (50659)
- Keisuke Hagihara (435273)
- Ryohei Ishii (19689)
- Mitsuru Higashimori (435274)
- Makoto Kaneko (435275)
- Hidetoshi Hasuwa (435276)
- Takeshi Miwa (435277)
- Kazuhiro Yamamoto (115929)
- Issei Komuro (48691)
Publication date
July 2013
DOIAbstract
<p>Data are mean ± SEM. HFrEF and HFpEF indicate heart failure with reduced and preserved ejection fraction, respectively; NYHA, New York Heart Association; BNP, brain natriuretic peptide; LV, left ventricular; and EF, ejection fraction.</p>*<p><i>P</i><0.05 vs. control group,</p>†<p><i>P</i><0.05 vs. HFrEF group.</p
Add to ORKG